Here, we describe the loss of the transcription factor SMAD1 in KMT2A-rearranged AML with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes by analyzing a panel of patient samples and selected cell lines. This evidence concerns the gene KMT2A and acute myeloid leukemia.